XI'AN CITY, SHAANXI PROVINCE, CHINA, January 21, 2026 /EINPresswire.com/ -- The global nootropics and wellness ...

Olalla Consulting LTD announces its continued expansion across the UK and EU, strengthening its position as a leading technical partner for beauty, skincare, and healthcare brands seeking regulatory c ...

Kopicko has observed growing consumer interest in skincare products positioned around naturally derived ingredients and simplified formulation philosophies.

Gelteq Limited ('Gelteq”) and Healthy Extracts™ Inc. ('Healthy Extracts”) today announced the signing of a Memorandum of Understanding ('MoU”) formalising a strategic partnership designed to ...

CTK recently completed FDA OTC registration and related compliance steps for three white-label suncare products: a sun lotion, sun stick, and sun serum. “OTC” refers to drug products that can be ...

Professionals and consumers alike are increasingly examining formulation approaches designed to support long-term skin ...

Life sciences companies from around the globe continued to favor North Carolina for both new sites and expanded operations in ...

Cata-Kor’s NMN formulation achieves NSF/ANSI 173 certification, verifying manufacturing integrity and label accuracy ...

Results from the phase 2b PROCEED trial of intravenous bocunebart (also known as Lu AG09222) showed that the drug was able to ...

HONG KONG, HONG KONG , HONG KONG, January 21, 2026 /EINPresswire.com/ -- As skincare science rapidly evolves toward ...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2025 Earnings Call Transcript February 11, 2026 Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.38 EPS, expectations were $-0.

Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded today, February 11 ...